Search

Search Constraints

You searched for: Author/Creator Collins, Colin C.

Search Results

1. Aneustat (OMN54) has aerobic glycolysis‐inhibitory activity and also immunomodulatory activity as indicated by a first‐generation PDX prostate cancer model. Issue 2 (1st March 2018)

2. Characterization of transcriptomic signature of primary prostate cancer analogous to prostatic small cell neuroendocrine carcinoma. Issue 12 (10th June 2019)

3. Enhanced anticancer activity of a combination of docetaxel and Aneustat (OMN54) in a patient‐derived, advanced prostate cancer tissue xenograft model. Issue 2 (15th December 2013)

4. Establishment and characterization of a novel treatment‐related neuroendocrine prostate cancer cell line KUCaP13. Issue 7 (1st June 2021)

7. SiNVICT: ultra-sensitive detection of single nucleotide variants and indels in circulating tumour DNA. (16th August 2016)

8. Targeting MCT4 to reduce lactic acid secretion and glycolysis for treatment of neuroendocrine prostate cancer. (14th June 2018)

10. The long noncoding RNA HORAS5 mediates castration‐resistant prostate cancer survival by activating the androgen receptor transcriptional program. Issue 5 (5th March 2019)